Munguva pfupi yapfuura, JYMed Technology Co., Ltd. yakazivisa kuti Leuprorelin Acetate, yakagadzirwa nerubatsiro rwayo Hubei JX Bio-Pharmaceutical Co., Ltd., yakabudirira kupasa kuongororwa kwekunyoresa zvinodhaka.
Yekutanga Drug Market Overview
Leuprorelin Acetate mushonga unobaiwa jekiseni unoshandiswa kurapa zvirwere zvinoenderana nehomoni, neiyo molecular formula C59H84N16O12•xC2H4O2. Ndiyo gonadotropin-releasing hormone agonist (GnRHa) inoshanda nekudzivisa pituitary-gonadal system. Pakutanga-yakagadzirwa neAbbVie uye Takeda Pharmaceutical, mushonga uyu unotengeswa pasi pemazita emhando dzakasiyana munyika dzakasiyana. MuUnited States, inotengeswa pasi pezita rechiratidzo LUPRON DEPOT, nepo kuChina, inotengeswa seYina Tong.
Nzira Yakajeka uye Mabasa Akanyatsotsanangurwa
Kubva 2019 kusvika 2022, tsvakiridzo yemishonga nekusimudzira zvakapedzwa, zvichiteverwa nekunyoreswa kweAPI munaKurume 2024, pakagamuchirwa chiziviso chekugamuchira. Ongororo yekunyoreswa kwezvinodhaka yakapfuura muna Nyamavhuvhu 2024. JYMed Technology Co., Ltd. yaive nebasa rekuvandudza nzira, kuvandudza nzira yekuongorora, zvidzidzo zvetsvina, kusimbisa chimiro, uye nzira yekusimbisa. Hubei JX Bio-Pharmaceutical Co., Ltd. ndiye aitungamira maitiro ekusimbisa kugadzirwa, yekuongorora nzira yekusimbisa, uye kugadzikana zvidzidzo zveAPI.
Kuwedzera Musika uye Kukura Kwekuda
Kuwedzera kwechiitiko chegomarara reprostate uye uterine fibroids kuri kufambisa kuwedzera kudiwa kweLeuprorelin Acetate. Musika wekuNorth America parizvino unotonga musika weLeuprorelin Acetate, nekuwedzera kwekushandisa kwehutano uye kugamuchirwa kwakanyanya kwematekinoroji matsva kuve iwo ekutanga madhiraivha ekukura. Panguva imwe chete, musika weAsia, kunyanya China, uri kuratidzawo kudiwa kwakasimba kweLeuprorelin Acetate. Nekuda kwekuita kwayo, kudiwa kwepasirese kwemushonga uyu kuri kuwedzera, nehukuru hwemusika hunotarisirwa kusvika pamadhora mazana matatu nemakumi mapfumbamwe nemakumi mapfumbamwe nemashanu panosvika 2031, zvichiratidza huwandu hwekukura kwegore (CAGR) hwe4.86% kubva 2021 kusvika 2031.
About JYMed
Shenzhen JYMed Technology Co., Ltd. (inozonzi JYMed) yakavambwa muna 2009, ichishanda mukutsvaga, kusimudzira, kugadzira, uye kutengesa kwepeptides uye zvigadzirwa zvine chekuita nepeptide. Iine imwe nzvimbo yekutsvagisa uye matatu makuru mabhesi ekugadzira, JYMed ndeimwe yevagadziri vakakura vemakemikari synthesized peptide APIs muChina. Iyo kambani yepakati R&D timu inozvirumbidza pamusoro pemakore makumi maviri echiitiko muindasitiri yepeptide uye yakabudirira kupfuura FDA ongororo kaviri. JYMed's yakazara uye inoshanda peptide maindasitiri system inopa vatengi huwandu hwakazara hwesevhisi, kusanganisira kusimudzira uye kugadzirwa kweanorapa peptides, veterinary peptides, antimicrobial peptides, uye cosmetic peptides, pamwe nekunyoresa uye kudzora tsigiro.
Main Bhizinesi Mabasa
1.Domestic uye pasi rose kunyoresa peptide APIs
2.Veterinary uye cosmetic peptides
3.Custom peptides uye CRO, CMO, OEM mabasa
4.PDC mishonga (peptide-radionuclide, peptide-diki molecule, peptide-protein, peptide-RNA)
Pamusoro peLeuprorelin Acetate, JYMed yakaendesa mafirita ekunyoresa kuFDA neCDE kune zvimwe zvakati wandei zvigadzirwa zveAPI, zvinosanganisira parizvino inozivikanwa GLP-1RA kirasi mishonga yakadai seSemaglutide, Liraglutide uye Tirzepatide. Vatengi venguva yemberi vachishandisa zvigadzirwa zveJYMed vanozokwanisa kunongedzera zvakananga nhamba yeCDE yekunyoresa kana nhamba yefaira reDMF pavanotumira zvikumbiro zvekunyoresa kuFDA kana CDE. Izvi zvichaderedza zvakanyanya nguva inodiwa pakugadzirira magwaro ekunyorera, pamwe nenguva yekuongorora uye mutengo wekuongorora chigadzirwa.
Taura nesu
Shenzhen JYMed Technology Co., Ltd.
Kero:8th&9th Floors, Building 1, Shenzhen Biomedical Innovation Industrial Park, No. 14 Jinhui Road, Kengzi Subdistrict, Pingshan District, Shenzhen
Runhare:+86 755-26612112
Webhusaiti:http://www.jymedtech.com/
Nguva yekutumira: Aug-29-2024